Keros Therapeutics, Inc. · NASDAQ:KROS
Seth Alpna received 7,142 Keros Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 3, 2026 · Filed Jun 5, 2026
On Jun 3, 2026, Seth Alpna (Director) received 7,142 Keros Therapeutics, Inc. shares as an award, leaving 12,392 shares. Filed Jun 5, 2026 (Form 4).
- Awarded
- 7,142 shares
- Holding after
- 12,392 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Common Stock | Award | 7,142 | 12,392 | Direct |
Source
Related
- Keros Therapeutics, Inc.
- Seth Alpna
- Keros Therapeutics, Inc. shareholders
- Form 4 · Seth Alpna · Jun 5, 2026
- Form 4 · Tanini Annita · Aug 20, 2026
- Form 4 · Lerner Lorena Raquel · Aug 20, 2026
- Form 4 · Cho Esther · Aug 20, 2026
- Form 4 · Newton Charles W. · Aug 20, 2026
- Form 4 · Bienaime Jean Jacques · Aug 19, 2026